Table 7 |
|||
|
Serologies of patients with ankylosing spondylitis stratified by fecal calprotectin |
|||
|
AS fCAL-positive versus fCAL-negative (cutoff 50 μg/g) |
|||
|
|
|||
|
Median AS fCAL-positive |
Median AS fCAL-negative |
P value |
|
|
|
|||
|
IgA ASCA (ELISA units) |
1.9 |
0.2 |
0.05 |
|
IgG ASCA (ELISA units) |
11.5 |
6.2 |
0.003 |
|
I2 (ELISA units) |
4 |
6.8 |
0.36 |
|
OmpC (ELISA units) |
8.4 |
6.1 |
0.34 |
|
Cbir1 Fla (ELISA units) |
27.2 |
16.2 |
0.002 |
|
ANCA (ELISA units) |
9.2 |
5 |
0.06 |
|
|
|||
|
ANCA, antineutrophil cytoplasmic antibodies; AS, ankylosing spondylitis; ASCA, anti-Saccharomyces cerevisiae antibody; CBir1, anti-flagellin; fCAL, fecal calprotectin; OmpC, anti-Escherichia coli outer membrane porin C. |
|||
|
Matzkies et al. Arthritis Research & Therapy 2012 14:R261 doi:10.1186/ar4106 |
|||